glp 1 effects on menstrual cycle Do GLP-1 weight loss drugs affect the cycle? Why Hormones Make Your Mood
Description
GLP-1 has been implicated as a cause of the metabolic success of surgeries performed to correct obesity but research in genetic mouse models challenges this assumption

Methods Qualitative, individual, semi-structured interviews were conducted in nine participants who were prescribed GLP-1 receptor agonists for the treatment of obesity and/or T2D

Risk ratios (RRs) and 95% CIs were pooled in random effects meta-analyses

Clinical trials have demonstrated that semaglutide can reduce hemoglobin A1c by 1.52.0% in patients with type 2 diabetes (SUSTAIN clinical trial program) and produce weight loss of 1015% of body weight over 68 weeks in obesity treatment (STEP clinical trial program)

Additional research is required to develop pharmacological agents capable of inducing the transdifferentiation of WAT into BAT tissue, thereby offering a potential therapeutic strategy for the treatment of obesity

The goal is to find the lowest effective dose and maintain it
